内容へ

一般外科

術後貧血の管理

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (新しいタブで開く)

Ball AM, Winstead PS.

出典‎: Pharmacotherapy 2008;28(11):1383-90.

インデックス‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (新しいタブで開く)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (新しいタブで開く)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

出典‎: Transplant Proc 2015;47(8):2548-51.

インデックス‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (新しいタブで開く)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (新しいタブで開く)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

出典‎: Lancet Haematol 2016;3(9):e415-25.

インデックス‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (新しいタブで開く)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (新しいタブで開く)

Posluszny JA Jr, Napolitano LM.

出典‎: Transfusion 2014;54(12):3026-34.

インデックス‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (新しいタブで開く)

Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (新しいタブで開く)

Sharma P, Barajas FJ, Krishnamoorthy P, Campo LM, Blumenthal E, Spinnell M.

出典‎: J Clin Gastroenterol 2015;49(3):206-11.

インデックス‎: PubMed 25144897

DOI‎: 10.1097/MCG.0000000000000200

https://www.ncbi.nlm.nih.gov/pubmed/25144897 (新しいタブで開く)